Opioidsubstitutionsbehandlung und Cannabiskonsum

  • Udo Schneider
  • Ingo Schäfer
  • Thomas Hillemacher
  • Konrad F Cimander
  • Dirk Wedekind
  • Steffen Weirich
  • Ursula Havemann-Reinecke

Abstract

OBJECTIVES: More than 30 % of patients participating in an opioid maintenance program consume cannabis. This article describes the effects of additional cannabis use during an opioid maintenance treatment program.

METHODS: Narrative literature research using online publication databases (MedLine, PubMed) RESULTS: The additional use of cannabis during an opioid maintenance treatment program may have negative side effects.

CONCLUSION: Cannabis use should be discussed with the patient. It is in principle not a reason for discontinuing an opioid maintenance treatment program.

Bibliographical data

Translated title of the contributionOpioid maintenance treatment and Cannabis use
Original languageGerman
ISSN0720-4299
DOIs
Publication statusPublished - 10.2019
PubMed 31404930